Mechanism of Action: CXCR4 and CXCL12 Signaling

Plerixafor 8HCl (AMD3100 8HCl) acts as a competitive antagonist at the CXCR4 receptor, a G protein-coupled receptor (GPCR) that is widely expressed on hematopoietic stem cells, immune cells, and numerous tumor cell types. Its endogenous ligand, CXCL12 (also known as stromal cell-derived factor-1, SDF-1), drives chemotaxis, cell survival, and tissue homing through CXCR4 activation.

By occupying the CXCR4 binding site, Plerixafor 8HCl prevents CXCL12 from engaging its receptor, thereby interrupting downstream signaling cascades including PI3K/Akt and MAPK pathways. This blockade disrupts the CXCL12–CXCR4 axis, which is implicated in stem cell retention within the bone marrow niche, tumor cell migration, and immune cell trafficking.

The compound exhibits an IC50 of 44 nM against CXCR4 receptor binding and an IC50 of 5.7 nM against CXCL12-mediated chemotaxis, indicating high potency in functional cellular assays.

Research Applications

Plerixafor 8HCl is employed across a broad range of biomedical research disciplines owing to its selective inhibition of the CXCR4–CXCL12 axis:

• Hematopoietic Stem Cell (HSC) Mobilization: Researchers use AMD3100 to mobilize HSCs and progenitor cells from the bone marrow into peripheral blood in animal models, enabling mechanistic studies of stem cell niche biology and engraftment.
• Oncology and Tumor Biology: The CXCR4–CXCL12 axis is overexpressed in many cancers and is associated with metastasis and tumor microenvironment interactions. Plerixafor 8HCl serves as a pharmacological tool to dissect these pathways in vitro and in vivo.
• Immunology: Investigators study CXCR4-dependent immune cell trafficking, including the migration of T cells, B cells, and dendritic cells, using this antagonist to probe chemokine biology.
• HIV Research: CXCR4 functions as a co-receptor for X4-tropic HIV-1 entry. AMD3100 has been used as a research tool to block viral entry in cell-based assays.
• Fibrosis and Organ Injury Models: The CXCL12–CXCR4 pathway has been implicated in fibrotic signaling; Plerixafor 8HCl is applied in preclinical models to evaluate pathway contributions.

These applications make Plerixafor 8HCl (SKU: P129846) a versatile reagent for laboratories working at the interface of cancer biology, immunology, and stem cell research.

Pharmacological Profile and Selectivity

Plerixafor 8HCl demonstrates nanomolar potency against CXCR4 with an IC50 of 44 nM for receptor binding inhibition. In functional chemotaxis assays, it is even more potent, with an IC50 of 5.7 nM against CXCL12-induced cell migration, reflecting tight coupling between receptor occupancy and downstream cellular response.

The compound was originally identified as a bicyclam macrocycle (AMD3100) and has been characterized as a selective CXCR4 antagonist. Selectivity data against other chemokine receptors and off-target panels should be confirmed in the primary literature and within the specific experimental system used in your laboratory.

As the octahydrochloride salt, Plerixafor 8HCl offers improved aqueous solubility compared to the free base form, facilitating preparation of stock solutions in aqueous buffers or cell culture media. Researchers are advised to prepare fresh working solutions and store lyophilized or solid material according to the supplier's datasheet recommendations.

Handling, Storage, and Solution Preparation

Proper handling of Plerixafor 8HCl is essential to maintain compound integrity and experimental reproducibility. The following general guidelines apply; always defer to the product datasheet (SKU: P129846) for lot-specific instructions:

• Storage: Store the solid material at the temperature indicated on the product datasheet (typically 2–8 °C or −20 °C depending on formulation). Protect from moisture and light.
• Solubility: As an octahydrochloride salt, the compound has appreciable solubility in water and aqueous buffers. Prepare stock solutions in sterile water, PBS, or DMSO as appropriate for your assay system and verify solubility empirically.
• Working Concentrations: Dilute stock solutions to the required working concentration in cell culture medium or assay buffer immediately before use. Avoid repeated freeze-thaw cycles to maintain activity.
• Safety: Handle in accordance with standard laboratory safety practices. Consult the Safety Data Sheet (SDS) before use.

Note: Storage conditions and solubility data should be verified against the current Aladdin product datasheet for SKU P129846, as lot-specific parameters may vary.

Ordering Information and Product Availability

Plerixafor 8HCl (AMD3100 8HCl) is available from Aladdin Scientific under SKU P129846. This product is supplied as the octahydrochloride salt of Plerixafor, formulated for research use.

For current pricing, available pack sizes, purity certificates, and Safety Data Sheets, please visit the Aladdin Scientific product page or contact your local Aladdin representative. Bulk quantities may be available upon request.

Intended Use: For research purposes only. Not for diagnostic, therapeutic, or human use.